(PI-024) The versatile use of a novel Dual Compression System (DCS)* in the management of limb edema originating from several common pathophysiology

Compression therapy, the gold standard venous insufficiency is likely underutilized on a range of lower extremity edema conditions.  Particularly diabetes foot ulcers traumatic wounds, orthopedic dehiscence, and below the knee amputations. 

A combination of a novel compression therapy (can treat may types of edema of variable origin including diabetes and DFUs.


Methods:

To study the use of the novel DCS system on many types of edema, over a 30-day period every application of DCS was recorded, with the primary diagnosis and any contributing secondary diagnosis that indicated compression use.    


Results:

1,090 patient visits occurred from 334 patients, 199 (60%) of who obtained compression at their first visit.  942 total compression bandages were done over 30 days, 248 on 199 patients, on their first visit.


Breakdown of 199: Venous Insufficiency 113, DFU 41, traumatic 23, orthopedic dehiscence 15, amputation dehiscence 4, BKA 3.  Of the 199 new compression patients, 102 (51%) had diabetes.

Discussion:

:  We demonstrate that the DCS product is extremely versatile and can treat several underserved edematous conditions related to edema.  Venous insufficiency dominated (56% patients), with DFU being the second most common indication (20%) of patients.  Dehiscence/trauma/amputation edema was also successfully treated though they were smaller in proportion.  For diabetes, detailed vascular analysis is a must and was performed in each case.  With this protective approach, it is noteworthy that 51% of our unique patient load was successfully treated with compression with no complications


Trademarked Items:

References: